These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11943794)

  • 1. Early cervical cancer rescreening.
    Morrell S; Mamoon H; O'Callaghan J; Taylor R; Ross J; Wain G
    J Med Screen; 2002; 9(1):26-32. PubMed ID: 11943794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
    Morrell S; Taylor R; Wain G
    J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes from a mass media campaign to promote cervical screening in NSW, Australia.
    Morrell S; Perez DA; Hardy M; Cotter T; Bishop JF
    J Epidemiol Community Health; 2010 Sep; 64(9):777-83. PubMed ID: 19822553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the New South Wales Cancer Council Pap Test Reminder Service.
    Mills AE; Simpson JM; Shelley JM; Turnbull DA
    Aust J Public Health; 1994 Jun; 18(2):170-5. PubMed ID: 7948334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of early rescreening in the National Cervical Screening Program, Australia.
    Mitchell H; Hocking J
    Aust N Z J Public Health; 2001 Aug; 25(4):334-8. PubMed ID: 11529614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program.
    Bobo JK; Shapiro JA; Schulman J; Wolters CL
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):620-30. PubMed ID: 15066928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR; Marshall CJ; Bentz JS
    Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid rescreening of cervical smears: an improved method of quality control.
    Dudding N
    Cytopathology; 1995 Apr; 6(2):95-9. PubMed ID: 7795170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy.
    Campbell E; Peterkin D; Abbott R; Rogers J
    Prev Med; 1997; 26(6):801-7. PubMed ID: 9388791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
    Cernescu EC; Anton G; Ruţă S; Cernescu C
    Roum Arch Microbiol Immunol; 2013; 72(2):93-104. PubMed ID: 24187808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical screening: population-based comparisons between self-reported survey and registry-derived Pap test rates.
    Mamoon H; Taylor R; Morrell S; Wain G; Moore H
    Aust N Z J Public Health; 2001 Dec; 25(6):505-10. PubMed ID: 11824984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.